Light-at-night, circadian disruption and breast cancer: Assessment of existing evidence

International Journal of Epidemiology

Volumn 38, Issue 4, 2009, Pages 963-970

  Stevens, Richard G ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Breast cancer; Circadian disruption; Clock; Light at night; Melatonin

Indexed keywords

CARCINOGEN; MELATONIN; TRANSCRIPTION FACTOR CLOCK;

ACCUMULATION RATE; ASSESSMENT METHOD; CANCER; CARCINOGEN; CIRCADIAN RHYTHM; DISEASE INCIDENCE; EPIDEMIOLOGY; ESTHETICS; HORMONE; NUMERICAL MODEL; PREDICTION;

ARTICLE; BLINDNESS; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CIRCADIAN RHYTHM; EPIDEMIOLOGICAL DATA; GENETIC ASSOCIATION; HORMONE SYNTHESIS; HUMAN; LIGHT AT NIGHT; NONHUMAN; PHOTOTRANSDUCTION; PRIORITY JOURNAL; SHIFT WORKER; SLEEP;

ANIMALS; BLINDNESS; BREAST NEOPLASMS; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LIGHT SIGNAL TRANSDUCTION; LIGHTING; MELATONIN; SLEEP; TIME FACTORS; WORK SCHEDULE TOLERANCE;

RODENTIA;

EID: 68849118737     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyp178     Document Type: Article

References (106)

1. Nemchin AA, Whitehouse MJ, Menneken M, Geisler T, Pidgeon RT, Wilde SA. A light carbon reservoir recorded in zircon-hosted diamond from the Jack Hills. Nature 2008;454:92-95.
2. Harder B. Deprived of darkness: The unnatural ecology of artificial light at night. Science News, 20 April 2002.
3. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004;6 229-39.
4. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 2005;34:405-12.
5. Parkin DM, Fernández LM. Use of statistics to assess the global burden of breast cancer. Breast J 2006;12(Suppl 1):S70-80.
6. Feigelson HS, Henderson BE. Estrogens and breast cancer. Carcinogenesis 1996;17:2279-84.
7. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: Collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 2002; 360:187-95.
8. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995;87:1681-85.
9. Nagata C, Kawakami N, Shimizu H. Trends in the incidence rate and risk factors for breast cancer in Japan. Breast Cancer Res Treat 1997;44:75-82.
10. Hahn RA, Moolgavkar SH. Nulliparity, decade of first birth, and breast cancer in Connecticut cohorts, 1855 to 1945: An ecological study. Am J Public Health 1989;79:1503-7.
11. Hsieh CC, Trichopoulos D, Katsouyanni K, Yuasa S. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer 1990;46:796-800.
12. Stevens RG. Electric power use and breast cancer: A hypothesis. Am J Epidemiol 1987;125:556-61.
13. Cohen M, Lippman M, Chabner B. Pineal gland and breast cancer. Lancet 1978;2:1381-82.
14. Travis RC, Allen DS, Fentiman IS, Key TJ. Melatonin and breast cancer: A prospective study. J Natl Cancer Inst 2004;96:475-82.
15. Schernhammer ES, Hankinson SE. Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 2005;97:1084-87.
16. Schernhammer ES, Berrino F, Krogh V et al. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2008;100:898-905.
17. Vujovic N, Davidson AJ, Menaker M. Sympathetic input modulates, but does not determine, phase of peripheral circadian oscillators. Am J Physiol Regul Integr Comp Physiol 2008;295:R355-60.
18. Stevens RG, Blask DE, Brainard GC et al. Meeting report: The role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect 2007;115:1357-62.
19. Sahar S, Sassone-Corsi P. Circadian clock and breast cancer: A molecular link. Cell Cycle 2007;6:1329-31.
20. Straif K, Baan R, Grosse Y et al. Carcinogenicity of shiftwork, painting, and fire-fighting. Lancet Oncol 2007;8:1065-66.
21. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001;93:1557-62.
22. Schernhammer ES, Laden F, Speizer FE et al. Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 2001;93:1563-68.
23. Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology 2006;17:108-11.
24. Tynes T, Hannevik M, Andersen A, Vistnes AI, Haldorsen T. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 1996;7:197-204.
25. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001;12:74-77.
26. Lie JA, Roessink J, Kjaerheim K. Breast cancer and night work among Norwegian nurses. Cancer Causes Control 2006;17:39-44.
27. O'Leary ES, Schoenfeld ER, Stevens RG et al. Electromagnetic fields and breast cancer on long Island Study Group. Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol 2006;164:358-66.
28. Schwartzbaum J, Ahlbom A, Feychting M. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health 2007; 33:336-43.
29. Kolstad HA. Nightshift work and risk of breast cancer and other cancers - a critical review of the epidemiologic evidence. Scand J Work Environ Health 2008;34:5-22.
30. Tokumaru O, Haruki K, Bacal K, Katagiri T, Yamamoto T, Sakurai Y. Incidence of cancer among female flight attendants: A meta-analysis. J Travel Med 2006;13: 127-32.
31. Hahn RA. Profound bilateral blindness and the incidence of breast cancer. Epidemiology 1991;2:208-10.
32. Feychting M, Osterlund B, Ahlbom A. Reduced cancer incidence among the blind. Epidemiology 1998;9:490-94.
33. Pukkala E, Verkasalo PK, Ojamo M, Rudanko SL. Visual impairment and cancer: A population-based cohort study in Finland. Cancer Causes Control 1999;10:13-20.
34. Kliukiene J, Tynes T, Andersen A. Risk of breast cancer among Norwegian women with visual impairment. Br J Cancer 2001;84:397-99.
35. Verkasalo PK, Pukkala E, Stevens RG, Ojamo M, Rudanko SL. Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br J Cancer 1999;80:1459-60.
36. Verkasalo PK, Lillberg K, Stevens RG et al. Sleep duration and breast cancer: A prospective cohort study. Cancer Res 2005;65 9595-600.
37. Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ. Self-reported and measured sleep duration: How similar are they? Epidemiology 2008;19:838-45.
38. Lockley SW, Skene DJ, Arendt J. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J Sleep Res 1999;8:175-83.
39. Pinheiro SP, Schernhammer ES, Tworoger SS, Michels KB. A prospective study on habitual duration of sleep and incidence of breast cancer in a large cohort of women. Cancer Res 2006;66:5521-25.
40. Wu AH, Wang R, Koh WP, Stanczyk FZ, Lee HP, Yu MC. Sleep duration, melatonin and breast cancer among Chinese women in Singapore. Carcinogenesis 2008;29:1244-48.
41. McElroy JA, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Egan KM. Duration of sleep and breast cancer risk in a large population-based case-control study. J Sleep Res 2006;15 241-49.
42. Hébert M, Martin SK, Lee C, Eastman CI. The effects of prior light history on the suppression of melatonin by light in humans. J Pineal Res 2002;33:198-203.
43. Erren TC, Piekarski C. Does winter darkness in the Arctic protect against cancer? The melatonin hypothesis revisited. Med Hypotheses 1999;53:1-5.
44. Soininen L, Järvinen S, Pukkala E. Cancer incidence among Sami in Northern Finland, 1979-1998. Int J Cancer 2002;100:342-46.
45. Haldorsen T, Tynes T. Cancer in the Sami population of North Norway, 1970-1997. Eur J Cancer Prev 2005;14:63-68.
46. Hassler S, Sjölander P, Grönberg H, Johansson R, Damber L. Cancer in the Sami population of Sweden in relation to lifestyle and genetic factors. Eur J Epidemiol 2008;23:273-80.
47. Kelly JJ, Lanier AP, Alberts S, Wiggins CL. Differences in cancer incidence among Indians in Alaska and New Mexico and U.S. Whites, 1993-2002. Cancer Epidemiol Biomarkers Prev 2006;15:1515-19.
48. Boysen T, Friborg J, Andersen A, Poulsen GN, Wohlfahrt J, Melbye M. The Inuit cancer pattern-the influence of migration. Int J Cancer 2008;122:2568-72.
49. Hill AB. The environment and disease: Association or causation? Proc R Soc Med 1965;58:295-300.
50. Stevens RG. Artificial lighting in the industrialized world: Circadian disruption and breast cancer. Cancer Causes Control 2006;17 501-7.
51. Kloog I, Haim A, Stevens RG, Barchana M, Portnov BA. Light at night co-distributes with incident breast but not lung cancer in the female population of Israel. Chronobiol Int 2008;25:65-81.
52. Fu L, Lee CC. The circadian clock: Pacemaker and tumor suppressor Nature Reviews. Cancer 2003;3:350-61.
53. Hastings MH, Reddy AB, Maywood ES. A clockwork web: Circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 2003;4:649-61.
54. Siepka SM, Yoo SH, Park J, Lee C, Takahashi JS. Genetics and neurobiology of circadian clocks in mammals. Cold Spring Harb Symp Quant Biol 2007;72:251-59.
55. Storch KF, Lipan O, Leykin I et al. Extensive and divergent circadian gene expression in liver and heart. Nature 2002;417 78-83.
56. Hunt T, Sassone-Corsi P. Riding tandem: Circadian clocks and the cell cycle. Cell 2007;129:461-64.
57. Stevens RG, Rea MS. Light in the built environment: Potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes Control 2001;12:279-87.
58. Stevens RG. Circadian disruption and breast cancer: From melatonin to clock genes. Epidemiology 2005;16: 254-58.
59. Zhu Y, Brown HN, Zhang Y, Stevens RG, Zheng T. Period3 structural variation: A circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomark Prev 2005;14:268-70.
60. Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 2002;295:1070-73.
61. Brainard GC, Provencio I. Photoreception for the Neurobehavioral Effects of Light in Humans. Vol. 31. CIE Light and Health Symposium II. Vienna: CIE, 2006, pp. 6-21.
62. Berson DM. Phototransduction in ganglion-cell photoreceptors. Pflugers Arch 2007;454:849-55.
63. Provencio I, Jiang G, De Grip WJ, Hayes WP, Rollag MD. Melanopsin: An opsin in melanophores, brain, and eye. Proc Natl Acad Sci USA 1998;95:340-45.
64. Brainard GC, Hanifin JP, Greeson JM et al. Action spectrum for melatonin regulation in humans: Evidence for a novel circadian photoreceptor. J Neurosci 2001;21:6405-12.
65. Lockley SW, Brainard GC, Czeisler CA. High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab 2003;88:4502-5.
66. Brainard GC, Hanifin JP. Photons, clocks, and consciousness. J Biol Rhythms 2005;20:314-25.
67. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP. Light suppresses melatonin secretion in humans. Science 1980;210:1267-69.
68. McIntyre IM, Norman TR, Burrows GD, Armstrong SM. Melatonin supersensitivity to dim light in seasonal affective disorder. Lancet 1990;335:488.
69. Higuchi S, Motohashi Y, Ishibashi K, Maeda T. Influence of eye colors of Caucasians and Asians on suppression of melatonin secretion by light. Am J Physiol Regul Integr Comp Physiol 2007a;292:R2352-56.
70. Higuchi S, Motohashi Y, Ishibashi K, Maeda T. Less exposure to daily ambient light in winter increases sensitivity of melatonin to light suppression. Chronobiol Int 2007b;24:31-43.
71. Monteleone P, Esposito G, La Rocca A, Maj M. Does bright light suppress nocturnal melatonin secretion more in women than men? J Neural Transm Gen Sect 1995;102:75-80.
72. Jöchle W. Trends in photophysiologic concepts. Ann NY Acad Sci 1964;117:88-104.
73. Khaetski IK. Effect of hypothalamo-pituitary lesions induced by constant illumination on development of induced mammary tumors in rats. Vopr Exp Oncol (Kiev) 1965;1:87-93.
74. Anisimov VN. The light-dark regimen and cancer development. Neuroendocrinol Lett 2002;23(Suppl 2):28-36.
75. Blask DE, Brainard GC, Dauchy RT et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 2005;65 11174-84.
76. Dauchy RT, Blask DE, Sauer LA. Preparation of the inguinal fat pad for perfusion in situ in the rat: A surgical technique that preserves continuous blood flow. Contemp Top Lab Anim Sci 2000;39 29-33.
77. Dauchy EM, Dauchy RT, Davidson LK et al. Human cancer xenograft perfusion in situ in rats: A new perfusion system that minimizes delivery time and maintains normal tissue physiology and responsiveness to growth-inhibitory agents. J Am Assoc Lab Anim Sci 2006;45 38-44.
78. Shah PN, Mhatre MC, Kothari LS. Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res 1984;44:3403-7.
79. Anderson LE, Morris JE, Sasser LB, Stevens RG. Effect of constant light on DMBA mammary tumorigenesis in rats. Cancer Lett 2000;148 121-26.
80. Trichopoulos D. Hypothesis: Does breast cancer originate in utero? Lancet 1990;335:939-40.
81. Stevens RG, Davis S, Thomas DB, Anderson LE, Wilson BW. Electric power, pineal function, and the risk of breast cancer. FASEB J 1992;6 853-60.
82. Zhu Y, Zheng T, Stevens RG, Zhang Y, Boyle P. Does "clock" matter in prostate cancer? Cancer Epidemiol Biomarkers Prev 2006;15 3-5.
83. Kubo T, Ozasa K, Mikami K et al. Prospective cohort study of the risk of prostate cancer among rotating-shift workers: Findings from the Japan collaborative cohort study. Am J Epidemiol 2006;164 549-55.
84. Conlon M, Lightfoot N, Kreiger N. Rotating shift work and risk of prostate cancer. Epidemiology 2007;18:182-83.
85. Kakizaki M, Inoue K, Kuriyama S et al. Ohsaki Cohort Study. Sleep duration and the risk of prostate cancer: The Ohsaki Cohort Study. Br J Cancer 2008;99:176-78.
86. Marino JL, Holt VL, Chen C, Davis S. Shift work, hCLOCK T3111C polymorphism, and endometriosis risk. Epidemiology 2008;19 477-84.
87. Viswanathan AN, Hankinson SE, Schernhammer ES. Night shift work and the risk of endometrial cancer. Cancer Res 2007;67:10618-22.
88. Schernhammer ES, Laden F, Speizer FE et al. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 2003;95:825-28.
89. Kawachi I, Colditz GA, Stampfer MJ et al. Prospective study of shift work and risk of coronary heart disease in women. Circulation 1995;92:3178-82.
90. Knutson KL, Van Cauter E. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci 2008;1129 287-304.
91. Srinivasan V, Smits M, Spence W et al. Melatonin in mood disorders. World J Biol Psychiatry 2006;7:138-51.
92. Kobayashi M, Wood PA, Hrushesky WJ. Circadian chemotherapy for gynecological and genitourinary cancers. Chronobiol Int 2002;19 237-51.
93. Lévi F, Filipski E, Iurisci I, Li XM, Innominato P. Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics. Cold Spring Harb Symp Quant Biol 2007; 72:465-75.
94. Rea MS, Bierman A, Figueiro MG, Bullough JD. A new approach to understanding the impact of circadian disruption on human health. J Circadian Rhythms 2008;6:7.
95. Sephton S, Spiegel D. Circadian disruption in cancer: A neuroendocrine-immune pathway from stress to disease? Brain Behav Immun 2003;17:321-28.
96. Garland CF, Garland FC, Gorham ED et al. The role of vitamin D in cancer prevention. Am J Public Health 2006; 96:252-61.
97. Cole RJ, Kripke DF, Wisbey J et al. Seasonal variation in human illumination exposure at two different latitudes. J Biol Rhythms 1995;10:324-34.
98. Blair A, Stewart P, Lubin JH, Forastiere F. Methodological issues regarding confounding and exposure misclassification in epidemiological studies of occupational exposures. Am J Indus Med 2007;50: 199-207.
99. Hansen J. Light at night, shiftwork, and breast cancer risk. J Natl Cancer Inst 2001;93:1513-15.
100. Wehr TA. In short photoperiods, human sleep is biphasic. Sleep Res 1992;1:103-7.
101. Brown WA. Acknowledging preindustrial patterns of sleep may revolutionize approach to sleep dysfunction. Psychiatric Times: Applied Neurology, 26 May 2006.
102. Gronfier C, Wright KP Jr, Kronauer RE, Jewett ME, Czeisler CA. Efficacy of a single sequence of intermittent bright light pulses for delaying circadian phase in humans. Am J Physiol Endocrinol Metab 2004; 287:E174-81.
103. Cajochen C, Münch M, Kobialka S et al. High sensitivity of human melatonin, alertness, thermoregulation, and heart rate to short wavelength light. J Clin Endocrinol Metab 2005;90:1311-16.
104. Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: The neuroendocrine/circadian melatonin signal. Endocrine 2005;27 179-88.
105. Ernst E, Schmidt K, Baum M. Complementary/alternative therapies for the treatment of breast cancer. A systematic review of randomized clinical trials and a critique of current terminology. Breast J 2006;12 526-30.
106. Wirz-Justice A, Kräuchi K, Cajochen C, Danilenko KV, Renz C, Weber JM. Evening melatonin and bright light administration induce additive phase shifts in dim light melatonin onset. J Pineal Res 2004;36 192-94.